This article is a description of the current situation in France with regard to occupational cancer: research, prevention, and occupation. Toxicologic experiments are carried out using in vitro and in vivo tests, particularly using transgenic mice. Several epidemiologic studies have been conducted over the last decades: population-based case-control studies; mortality studies and cancer incidence studies carried out in historical cohorts of workers employed in the industry; and case-control studies nested in occupational cohorts. French ethical aspects of toxicologic and epidemiologic studies are described. The results thus obtained are used to establish regulations for the prevention and the compensation of cancers attributable to occupational exposure. This French regulation for prevention of occupational cancer involves several partners: a) the states authorities, including labor inspectors, responsible for preparing and implementing the labor legislation and for supervising its application, particularly in the fields of occupational health and safety and working conditions; b) the Social Security Organisation for the analysis of present or potential occupational risks based on tests, visits in plants, complaints or requests from various sources, and statistics. These activities are performed within the framework of the general French policy for the prevention of occupational cancer. This organization includes the National Institute for Research and Safety, particularly involved in research in the various fields of occupational risks-animal toxicology, biologic monitoring, exposure measurements epidemiology, psychology, ergonomy, electronic systems and machineries, exposure to chemicals, noise, heat, vibration, and lighting; and c) companies where the regulation defines the role of the plant manager, the occupational physician, and the Health, Safety and Working Conditions Committee (comprising the manager, employees' representatives, the occupational physician, and the safety department) in dealing with any problem regarding safety, occupational hygiene, and working conditions. These organizations along with medical practitioners are involved with the compensation of occupational cancers. The regulation for compensation includes the tables of occupational cancer, the possibility of recognition of a cancer case when the requirements of the tables are not met, and the postprofessional follow-up of workers exposed to a carcinogenic agent. -Environ Health Perspect 107(Suppl 2): 245-252 (1999). http.//ehpnetl.niehs.nih.gov/docs/1999/Suppl-21245-252aubrun/abstract.html
industrialized countries in the world. Several institutions or organizations are involved in the various topics resulting from occupational cancer detection and prevention including activities such as toxicology, epidemiology, regulation for compensation, and threshold limit values. Although these topics are not specific to French working conditions, some of the methods that deal with these problems depend on French legislation.
This article is an overview of the occupational cancer problem in France. The various topics discussed are a) research in epidemiology and in animal toxicology, b) the situation concerning exposures to known carcinogens, and c) the status of regulations on occupational exposure to carcinogens, occupational cancer deserving compensation, and prevention of occupational exposure. The roles of occupational physicians and medical practitioners in this field are also described. 
Epidemiologic Studies
O
Case-Contol Studies
This section deals with population-based case-control studies only (1) . Several independent case-control studies on occupational risk factors of cancer have been conducted in France (2) . Almost half these studies have investigated occupational risk factors of lung or other respiratory cancers (2) . The other sites of cancer most frequently studied were cancers of the hematopoietic system and urinary bladder (2) .
Sources ofCases. Most (3) . For a given study, the local clinicians and pathologists who systematically report all cancer cases to the registry may be asked to report the new cases of the specific site of cancer to the study investigator at the time of diagnosis. Some studies have already been conducted in this way by cancer registries or with their collaboration (2) . This procedure for recruiting the cases in population-based case-control studies may become more frequent in the future.
Source of Controls. When cases are recruited among hospitalized patients, hospital-based controls are also used. The controls may be other cancer patients or noncancer patients. The advantages and the limitations of this procedure for selecting controls are not specific to France (1) . Controls may be selected among different groups of diagnoses to control for possible selection biases (1) Data on lifestyle such as smoking habits can be collected from medical records of each plant for present and past workers.
Occupational Exposure Assessment. Exposure measurements can be performed by the INRS, the Regional Health Insurance Funds (CRAMs), or some universities. They provide information on current exposure. Past exposure can be assessed using available past measurements and through the development of job exposure matrices specific to the industrial process of interest (9, 10) .
Statistical Analysis. Standard mortality ratios are calculated as recommended in the literature (5, 6) . The reference death rates are published by the INSERM, at the national or regional level (95 French districts). They provide the numbers of causes of deaths according to sex, 5-year age groups, and year of death since 1968. Data from the INSEE provide the corresponding numbers of subjects for the calculation of death rates.
Ethlics in Epideologic S
The conduct of epidemiologic studies in France has to meet the requirements of legislative or regulatory guidelines that are intended to protect the study subjects Environmental Health Perspectives * Vol 107, Supplement 2 * May 1999 (11) (12) (13) (14) . These guidelines cover three broad areas: * The automated treatment of nominative information (11, 12) (19) , and long-term carcinogenesis studies (20, 21) constitute the methodologic corpus of this assessment.
Mechanistic studies include research on the understanding of the production and the target effects of free radicals, the cellular effects of proliferation and apoptosis, the formation of DNA adducts, the direct or indirect mutagenic effect on DNA, the change of gene expression, and the analysis of the physicochemical properties of susceptible particle surfaces to explain their differences in biologic activity. Only two types of tests can be used in in vitro carcinogenesis testing (22) (23) (24) (25) : the morphologic transformation of mammalian cells in culture (26, 27) and the inhibition of metabolic cooperation (28) . Current research works use the survey of methodologic parameters to improve their predictiveness.
For in vivo assessment, methods in molecular biology led to the creation and use of transgenic animal models from 1984 (29, 30 (31) , it is our responsibility to respect the animal subjects and consider their capacities for suffering and remembering. The ethical principles imposed by current legislation are based on the "three Rs" of Russel and Burch (32): replace, reduce, and refine (33) (34) (35) .
French legislation is designed to conform to the European and French texts on this issue, particularly with Council Directive no. 86/609/EEC of 24/11/1986 (36) and the French Decree no. 87-848 of 19/10/1987 (37,38) .
Currently there are no regulatory texts on the creation of ethics committees because the system chosen by France is based on an authorization delivered to responsible and competent individuals (conforming to article 7-1 of the Council Directive no. 86/609/EEC) (32) . Because of the application of this set of directives, the number of animals used in experiments has decreased 25% over the last 10 years without causing a reduction in research activity (39, 40 Since 1995, the French Ministry of Labour has recommended a threshold limit value of 1.5 f/ml (1 fiber in 1997) for mineral wools and 1 f/ml (0.6 f/ml in 1997) for ceramic fibers.
Silica. Silica exposure in the occupational environment is extremely frequent (46) . Mines and quarries are exposed workplaces that employed nearly half a million persons in France after War World II. Today this population is restricted to less than 30,000 workers. Specific health and safety regulations are involved in this sector, including a threshold limit value for occupational exposure to free silica at 0. 25 (47) . Lung cancer can be compensated as a complication of siderosis in France.
Apart from extractive industries, silica exposure is frequent, mainly in building industries that include tunneling, ceramic production, abrasive production, and glass manufacture. It is possible to give a precise number of workers involved based on identification by occupational physicians of subjects included in the special silica medical survey. Probably more than 1 % of active workers are involved. Organization of preventive strategies is slightly different from that of extractive industries, with a threshold limit value of 0.1 mg/m3 for quartz. The medical survey is also based on annual chest X-ray and spirometry during and after exposure. The main sample of compensation exists as in extraction industries; in 1993, 226 new cases of silicosis were compensated. There was a significant decrease from the 1980s (around 600 cases), but values have been stable since 1988 (42) . This must be considered in the evaluation of a potential carcinogen risk.
Wood Dusts. Sinonasal cancers are well related to occupational exposure to wood dust, as recently reported in an important case-control study conducted in France from 1986 to 1988 (48) . It was reported that risk was higher for hard wood and adenocarcinoma; all but 2 of the 82 male cases with adenocarcinoma were exposed. A 2-fold increase in risk was observed for squamous cell carcinoma. Moreover, another analysis of the same population has suggested an interaction with other chemicals such as formaldehyde, glues, and adhesives. As exposure to all those products is highly correlated, the exact model of this interaction could not be correctly described (49) .
However, it is still difficult to assess precisely the number of exposed workers. Cases of sinonasal cancer among woodworkers are compensated as occupational diseases and the number of compensated cases during the past decade ranged between 20 and 40 each year (42 Technical Measures. In addition to specific provisions, technical measures must be applied: a) the employer shall regularly assess the nature, level, and duration of exposure, taking all exposure routes (inhalation, ingestion, percutaneous penetration) into account; b) the employer shall reduce to a minimum the use of carcinogenic agents, in particular by replacing them with less dangerous products or processes; c) the employer shall reduce to a minimum the duration of exposure and the number of exposed workers; and d) the employer shall provide the necessary protective equipment and keep it in good condition.
Medical Examination. Before being employed in a workplace where exposure to carcinogens is likely to occur, each worker must undergo an ad hoc medical examination by the occupational physician of the plant. This examination shall be performed every 6 months. For each worker, a medical record shall be set up and archived, indicating a description of the work, the duration of exposure, and the results of clinical and biologic examinations. This record is to be archived for at least 40 years after the end of exposure. If the worker moves to another company, the medical record relating to occupational exposure is transmitted to the occupational physician.
Training and Information. The employer shall organize appropriate safety training for workers exposed to cancer risks with the advice of occupational physicians and CHSCT. The employer shall also inform the workers, the occupational physician, the members of the CHSCT, and the competent health and safety inspectors of the hazards associated with the products used, the work organization, the incidents that have occurred, and the safety measures that have been implemented. In particular, the employer shall ensure that all products are adequately labeled.
Restriction and Prohibition of Use. Decree no. 89-593 (55) following European Directive 88/364/EEC (56) prohibited the production and use (except for research, scientific analysis, or disposal purposes) of preparations containing more than 0.1 % (weight percentage) of four carcinogenic substances (55) .
Other provisions prohibit the appointment of different categories of workers (workers under a fixed-term contract of employment, temporary workers, young workers) for certain jobs (e.g., asbestos work).
When workers have to carry out tasks on the premises of another company and when those tasks involve possible exposure to carcinogenic agents, both employers must jointly draw up a written prevention plan before work starts.
Special 
Postprofssional Foliow-Up
In addition to these regulations, the postprofessional follow-up procedure was set up in 1993 (54). This consists of health surveillance of workers after their occupational exposures to carcinogenic risk or processes (61) . This follow-up is made by physicians, occupational physicians, or medical practitioners for all workers who provide a certificate of exposure written by the manager and the occupational physician of the activity of interest.
Ocpationl Cancs Deserving

Compensation
The tables concerning lung cancer are related to exposure to asbestos, arsenic dusts and vapors, bischloromethylether, coal tars and oils, coal tar pitch, soot, chromic acid, chromates, roasting of nickel matte, ionizing radiation, and iron oxide dust in iron ore mining (lung cancer with siderosis) (58) (59) (60) .
The tables concerning other cancer are (58-60) bladder (exposure to N-nitrosobutylamine, aromatic amines, coal tars and oils, coal tar pitch, and soot), nose and sinuses (exposure to wood dust and to roasting of nickel matte), pleural mesothelioma (exposure to asbestos), leukemia (exposure to ionizing radiation and benzene exposure), sarcoma (exposure to ionizing radiation), angiosarcoma of the liver (exposure to vinyl chloride), and skin (exposure to coal tars and oils, coal tar pitch, soot, and mineral oils).
Number of Compensatd cer C Despite the great number of the abovementioned occupational cancer tables, the number of compensated cases remains low compared to the size of the French population. The number of compensated cancer cases has been rising from about 50 compensated cases per year in the 1970s to about 150 to 200 cases during the 1990s (62, 63) . About 50% of compensated cases in the 1990s are due to asbestos (84 mesothelioma and 33 lung cancer in 1994) (64) . According to the published estimates suggesting that about 4% of all cancer cases could be attributable to occupational exposure (65) , the number of occupational cancer cases deserving compensation would be approximately 7,000 each year in France (62, 63 
